← Leaderboards
Zhao-Hui Song
University Of Louisville
$4,182,259
Attributed
$4,822,268
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $856.5K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,822,268 · 6
By mechanism
R01$3,235,678 · 2
R21$1,280,019 · 3
R29$306,571 · 1
Top collaborators
- Hui Shao2 shared
- Wenke Feng1 shared
- Shigeo Tamiya1 shared
Others in their field
Top investigators on “Cannabinoids”
- Alexandros Makriyannis · University Of Connecticut Storrs$39,379,878
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$31,535,958
- Deepak Cyril D'souza · Va Connecticut Healthcare System$18,310,025
- Daniele Piomelli · University Of California Irvine$17,726,721
- Kenneth P. Mackie · Queen'S Medical Center$16,568,516
- Jenny L. Wiley · Virginia Commonwealth University$14,895,613
Research focus
CannabinoidsCannabinoid ReceptorLigandsAgonistInflammationGlaucomaReceptorDesignCellsPharmaceutical PreparationsImmuneFutureTherapeutic AgentsMediatingProtein Structure FunctionPeptidesAutoimmune DiseasesAdverse EffectsMolecular BiologyPlayG-Protein-Coupled ReceptorsBlindnessMarihuanaFamily
Grant awards (19)
Endocannabinoid system as a therapeutic target for PVR$445,262
R21 · FY2023 · EY · contact PI
Cannabidiol as a treatment for alcoholic liver disease$411,257
R21 · FY2023 · AA · contact PI
The effect of cannabidiol and the role of GPR3 in experimental autoimmune uveitis$192,500
R21 · FY2020 · EY
The effect of cannabidiol and the role of GPR3 in experimental autoimmune uveitis$231,000
R21 · FY2019 · EY
Cannabinoid Receptors and Novel Antiglaucoma Drugs$370,000
R01 · FY2010 · EY · contact PI
Cannabinoid Receptors and Novel Antiglaucoma Drugs$370,000
R01 · FY2009 · EY · contact PI
Structure and Function of CB2 Cannabinoid Receptor$278,588
R01 · FY2008 · DA · contact PI
Structure and Function of CB2 Cannabinoid Receptor$243,920
R01 · FY2007 · DA · contact PI
Structure and Function of CB2 Cannabinoid Receptor$40,354
R01 · FY2007 · DA · contact PI
Cannabinoid Receptors and Novel Antiglaucoma Drugs$287,091
R01 · FY2006 · EY · contact PI
Structure and Function of CB2 Cannabinoid Receptor$251,205
R01 · FY2006 · DA · contact PI
Cannabinoid Receptors and Novel Antiglaucoma Drugs$294,000
R01 · FY2005 · EY
Structure and Function of CB2 Cannabinoid Receptor$257,250
R01 · FY2005 · DA
Cannabinoid Receptors and Novel Antiglaucoma Drugs$294,000
R01 · FY2004 · EY
Structure and Function of CB2 Cannabinoid Receptor$257,104
R01 · FY2004 · DA
Cannabinoid Receptors and Novel Antiglaucoma Drugs$292,166
R01 · FY2003 · EY
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR$105,182
R29 · FY2002 · DA
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR$102,161
R29 · FY2001 · DA
STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR$99,228
R29 · FY2000 · DA